IL290250A - טיפול גנטי ממוקד לטיפול במחלות נוירולוגיות - Google Patents

טיפול גנטי ממוקד לטיפול במחלות נוירולוגיות

Info

Publication number
IL290250A
IL290250A IL290250A IL29025022A IL290250A IL 290250 A IL290250 A IL 290250A IL 290250 A IL290250 A IL 290250A IL 29025022 A IL29025022 A IL 29025022A IL 290250 A IL290250 A IL 290250A
Authority
IL
Israel
Prior art keywords
gene therapy
neurological diseases
targeted gene
treat neurological
treat
Prior art date
Application number
IL290250A
Other languages
English (en)
Original Assignee
Univ Cornell
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Cornell filed Critical Univ Cornell
Publication of IL290250A publication Critical patent/IL290250A/he

Links

IL290250A 2019-08-01 2022-01-31 טיפול גנטי ממוקד לטיפול במחלות נוירולוגיות IL290250A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962881540P 2019-08-01 2019-08-01
PCT/US2020/044598 WO2021022208A1 (en) 2019-08-01 2020-07-31 Targeted gene therapy to treat neurological diseases

Publications (1)

Publication Number Publication Date
IL290250A true IL290250A (he) 2022-04-01

Family

ID=72145498

Family Applications (1)

Application Number Title Priority Date Filing Date
IL290250A IL290250A (he) 2019-08-01 2022-01-31 טיפול גנטי ממוקד לטיפול במחלות נוירולוגיות

Country Status (3)

Country Link
EP (1) EP4007609A1 (he)
IL (1) IL290250A (he)
WO (1) WO2021022208A1 (he)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024148192A1 (en) * 2023-01-05 2024-07-11 Emugen Therapeutics Llc Chimeric aav and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797368A (en) 1985-03-15 1989-01-10 The United States Of America As Represented By The Department Of Health And Human Services Adeno-associated virus as eukaryotic expression vector
US4863457A (en) 1986-11-24 1989-09-05 Lee David A Drug delivery device
US5378475A (en) 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
US5464758A (en) 1993-06-14 1995-11-07 Gossen; Manfred Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters
US5814618A (en) 1993-06-14 1998-09-29 Basf Aktiengesellschaft Methods for regulating gene expression
US5443505A (en) 1993-11-15 1995-08-22 Oculex Pharmaceuticals, Inc. Biocompatible ocular implants
US6342390B1 (en) 1994-11-23 2002-01-29 The United States Of America As Represented By The Secretary Of Health And Human Services Lipid vesicles containing adeno-associated virus rep protein for transgene integration and gene therapy
FR2814642B1 (fr) 2000-10-03 2005-07-01 Ass Pour Le Dev De La Rech En Souris transgenique pour la recombinaison ciblee mediee par la cre-er modifiee
US6723551B2 (en) 2001-11-09 2004-04-20 The United States Of America As Represented By The Department Of Health And Human Services Production of adeno-associated virus in insect cells
MA44546B1 (fr) * 2016-06-15 2021-03-31 Univ California Virus adéno-associés variants et procédés d'utilisation
US20200054711A1 (en) * 2017-02-28 2020-02-20 The Penn State Research Foundation Regenerating functional neurons for treatment of neural injury caused by disruption of blood flow

Also Published As

Publication number Publication date
WO2021022208A1 (en) 2021-02-04
EP4007609A1 (en) 2022-06-08

Similar Documents

Publication Publication Date Title
HK1246712A1 (zh) 神經刺激治療疾病及病症
IL288574A (he) אוליגונוקליאוטידים ושיטות לשימוש לטיפול במחלות נוירולוגיות
IL284554A (he) מבנים לתרפיה גנטית לטיפול במחלת ווילסון
EP3364970A4 (en) METHODS OF TREATING NEURODEGENERATIVE DISEASES USING GENE THERAPY TO DELAY THE TRIGGERING AND EVOLUTION OF THE DISEASE WHILE CONFERRING COGNITIVE PROTECTION
IL279918A (he) וקטורי טיפול גני לטיפול במחלת דנון
ZA201903003B (en) Treatment of neurological diseases
IL285238A (he) וקטורי ריפוי גנים לטיפול במחלת דנון
HK1253299A1 (zh) 一種通過基因治療治療眼疾病的改進方法
EP4055033A4 (en) COMBINATION THERAPY FOR THE TREATMENT OF BRAIN CANCER
SG11202101819QA (en) Gene therapy for the treatment of galactosemia
GB202114972D0 (en) Gene therapy
EP3413898A4 (en) USE OF TREHALOSIS FOR THE TREATMENT OF NEUROLOGICAL DISEASES
GB201914034D0 (en) Treatment of neurological disorders
GB202003618D0 (en) Gene Therapy
IL290250A (he) טיפול גנטי ממוקד לטיפול במחלות נוירולוגיות
IL282360A (he) טיפול למחלות נוירולוגיות
IL284411A (he) הובלה מכוונת של מולקולות תרופתיות
GB202003109D0 (en) Gene therapy
GB202002202D0 (en) Gene therapy
EP4247958A4 (en) TARGETING HOST-BACTERIAL INTERACTIONS FOR THE TREATMENT OF MICROBIOTA-MEDIATED DISEASES
GB202005321D0 (en) Gene therapy treatment
EP3952856A4 (en) GENE VARIANTS ASSOCIATED WITH RESPONSE TO THE TREATMENT OF NEUROLOGICAL DISORDERS
GB201706662D0 (en) Treatment of neurological diseases
IL310018A (he) ריפוי גנים kcnv2
IL310017A (he) ריפוי גנים retgc